These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17419063)

  • 1. Why are prion diseases precluded by non-mammals?
    Ji HF; Zhang HY; Chen LL
    Trends Biochem Sci; 2007 May; 32(5):206-8; discussion 208. PubMed ID: 17419063
    [No Abstract]   [Full Text] [Related]  

  • 2. Prion diseases. Yielding under the strain.
    Weissmann C
    Nature; 1995 Jun; 375(6533):628-9. PubMed ID: 7791890
    [No Abstract]   [Full Text] [Related]  

  • 3. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prions: proof of proteinaceous nature but problems with population polymorphisms.
    Griffiths PD
    Rev Med Virol; 2004; 14(6):341-3. PubMed ID: 15495195
    [No Abstract]   [Full Text] [Related]  

  • 5. Deadly conformations--protein misfolding in prion disease.
    Horwich AL; Weissman JS
    Cell; 1997 May; 89(4):499-510. PubMed ID: 9160742
    [No Abstract]   [Full Text] [Related]  

  • 6. [Molecular pathogenesis of spongiform encephalopathy].
    Aguzzi A; Maddalena A; Brandner S; Klein M
    Pathologica; 1997 Oct; 89(5):481-90. PubMed ID: 9489393
    [No Abstract]   [Full Text] [Related]  

  • 7. Prion protein biology.
    Prusiner SB; Scott MR; DeArmond SJ; Cohen FE
    Cell; 1998 May; 93(3):337-48. PubMed ID: 9590169
    [No Abstract]   [Full Text] [Related]  

  • 8. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prion paradox: infection or polymerisation?
    Biro JC
    Appl Bioinformatics; 2003; 2(3 Suppl):S25-30. PubMed ID: 15130813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photo-induced crosslinking of prion protein oligomers and prions.
    Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
    Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mathematical analysis of the dynamics of prion proliferation.
    Greer ML; Pujo-Menjouet L; Webb GF
    J Theor Biol; 2006 Oct; 242(3):598-606. PubMed ID: 16753184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomedicine. A view from the top--prion diseases from 10,000 feet.
    Priola SA; Chesebro B; Caughey B
    Science; 2003 May; 300(5621):917-9. PubMed ID: 12738843
    [No Abstract]   [Full Text] [Related]  

  • 13. [What are the prions?].
    Piédrola Angulo G
    An R Acad Nac Med (Madr); 2001; 118(3):599-604. PubMed ID: 11783039
    [No Abstract]   [Full Text] [Related]  

  • 14. Prion propagation and molecular chaperones.
    Zahn R
    Q Rev Biophys; 1999 Nov; 32(4):309-70. PubMed ID: 11194568
    [No Abstract]   [Full Text] [Related]  

  • 15. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential solubility of prions is associated in manifold phenotypes.
    Kuczius T; Karch H; Groschup MH
    Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transmembrane form of the prion protein in neurodegenerative disease.
    Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
    Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of methionine 216 in sheep and elk prion protein is highly dependent upon the amino acid at position 218 but is not important for prion propagation.
    Silva CJ; Dynin I; Erickson ML; Requena JR; Balachandran A; Hui C; Onisko BC; Carter JM
    Biochemistry; 2013 Mar; 52(12):2139-47. PubMed ID: 23458153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of transgenic mice in the investigation of transmissible spongiform encephalopathies.
    Weissmann C; Fischer M; Raeber A; Büeler H; Sailer A; Shmerling D; Rülicke T; Brandner S; Aguzzi A
    Int J Exp Pathol; 1996 Dec; 77(6):283-93. PubMed ID: 9155663
    [No Abstract]   [Full Text] [Related]  

  • 20. Some implications of the prion paradigm: caveat denaturor.
    Lederberg J
    JAMA; 1999 Oct; 282(14):1332-3. PubMed ID: 10527177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.